Acknowledgement
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Korea government (NRF-2014R1A1A1003163).
References
- Steinmann, G. G. 1986. Changes in the human thymus during aging. Curr. Top. Pathol. 75: 43-88. https://doi.org/10.1007/978-3-642-82480-7_2
- Taub, D. D., W. J. Murphy, and D. L. Longo. 2010. Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways. Curr. Opin. Pharmacol. 10: 408-424. https://doi.org/10.1016/j.coph.2010.04.015
- Berczi, I., A. Quintanar-Stephano, and K. Kovacs. 2009. Neuroimmune regulation in immunocompetence, acute illness, and healing. Ann. N. Y. Acad. Sci. 1153: 220-239. https://doi.org/10.1111/j.1749-6632.2008.03975.x
- Gruver, A. L., and G. D. Sempowski. 2008. Cytokines, leptin, and stress-induced thymic atrophy. J. Leukoc. Biol. 84: 915-923. https://doi.org/10.1189/jlb.0108025
- Billard, M. J., A. L. Gruver, and G. D. Sempowski. 2011. Acute endotoxin-induced thymic atrophy is characterized by intrathymic inflammatory and wound healing responses. PLoS One 6: e17940.
- Wang, S. D., K. J. Huang, Y. S. Lin, and H. Y. Lei. 1994. Sepsis-induced apoptosis of the thymocytes in mice. J. Immunol. 152: 5014-5021. https://doi.org/10.4049/jimmunol.152.10.5014
- Lee, J. H., K. Patel, H. J. Tae, A. Lustig, J. W. Kim, M. P. Mattson, and D. D. Taub. 2014. Ghrelin augments murine T-cell proliferation by activation of the phosphatidylinositol-3-kinase, extracellular signal-regulated kinase and protein kinase C signaling pathways. FEBS Lett. 588: 4708-4719. https://doi.org/10.1016/j.febslet.2014.10.044
- Baatar, D., K. Patel, and D. D. Taub. 2011. The effects of ghrelin on inflammation and the immune system. Mol. Cell. Endocrinol. 340: 44-58. https://doi.org/10.1016/j.mce.2011.04.019
- Prodam, F., and N. Filigheddu. 2014. Ghrelin gene products in acute and chronic inflammation. Arch. Immunol. Ther. Exp. (Warsz.) 62: 369-384. https://doi.org/10.1007/s00005-014-0287-9
- DeBoer, M. D. 2012. The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism. Curr. Pharm. Des 18: 4779-4799. https://doi.org/10.2174/138161212803216951
- Lee, J. H., M. Halperin-Sheinfeld, D. Baatar, M. R. Mughal, H. J. Tae, J. W. Kim, A. Carter, A. Lustig, O. Snir, G. Lavie, E. Okun, M. P. Mattson, B. Sredni, and D. D. Taub. 2014. Tellurium compound AS101 ameliorates experimental autoimmune encephalomyelitis by VLA-4 inhibition and suppression of monocyte and T cell infiltration into the CNS. Neuromolecular Med. 16: 292-307. https://doi.org/10.1007/s12017-013-8277-3
- Tesauro, M., F. Schinzari, M. Caramanti, R. Lauro, and C. Cardillo. 2010. Cardiovascular and metabolic effects of ghrelin. Curr. Diabetes Rev. 6: 228-235. https://doi.org/10.2174/157339910791658871
- Zhang, G. G., H. Q. Cai, Y. H. Li, Y. B. Sui, J. S. Zhang, J. R. Chang, M. Ning, Y. Wu, C. S. Tang, Y. F. Qi, and X. H. Yin. 2013. Ghrelin protects heart against ERS-induced injury and apoptosis by activating AMP-activated protein kinase. Peptides 48: 156-165. https://doi.org/10.1016/j.peptides.2013.08.015
- Baldelli, R., S. Bellone, F. Broglio, E. Ghigo, and G. Bona. 2004. Ghrelin: a new hormone with endocrine and non-endocrine activities. Pediatr. Endocrinol. Rev. 2: 8-14.
- Veldhuis, J. D., and C. Y. Bowers. 2010. Integrating GHS into the Ghrelin System. Int. J. Pept. pii: 879503
- Dixit, V. D., H. Yang, Y. Sun, A. T. Weeraratna, Y. H. Youm, R. G. Smith, and D. D. Taub. 2007. Ghrelin promotes thymopoiesis during aging. J.Clin.Invest 117: 2778-2790. https://doi.org/10.1172/JCI30248
- El-Missiry, M. A. 2012. Antioxidant Enzyme. InTech, Rijeka, Croatia. p. 303-320.
- Huang, H., and D. J. Tindall. 2006. FOXO factors: a matter of life and death. Future Oncol. 2: 83-89. https://doi.org/10.2217/14796694.2.1.83
- Huang, H., and D. J. Tindall. 2007. Dynamic FoxO transcription factors. J. Cell Sci. 120: 2479-2487. https://doi.org/10.1242/jcs.001222
- Burgering, B. M., and R. H. Medema. 2003. Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J. Leukoc. Biol. 73: 689-701. https://doi.org/10.1189/jlb.1202629
- Patel, K., V. D. Dixit, J. H. Lee, J. W. Kim, E. M. Schaffer, D. Nguyen, and D. D. Taub. 2012. The GHS-R blocker D-[Lys3] GHRP-6 serves as CCR5 chemokine receptor antagonist. Int. J. Med. Sci. 9: 51-58. https://doi.org/10.7150/ijms.9.51
- Baldanzi, G., N. Filigheddu, S. Cutrupi, F. Catapano, S. Bonissoni, A. Fubini, D. Malan, G. Baj, R. Granata, F. Broglio, M. Papotti, N. Surico, F. Bussolino, J. Isgaard, R. Deghenghi, F. Sinigaglia, M. Prat, G. Muccioli, E. Ghigo, and A. Graziani. 2002. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell Biol. 159: 1029-1037. https://doi.org/10.1083/jcb.200207165
- Granata, R., F. Settanni, L. Biancone, L. Trovato, R. Nano, F. Bertuzzi, S. Destefanis, M. Annunziata, M. Martinetti, F. Catapano, C. Ghe, J. Isgaard, M. Papotti, E. Ghigo, and G. Muccioli. 2007. Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl inositol 3-Kinase/Akt signaling. Endocrinology 148: 512-529. https://doi.org/10.1210/en.2006-0266
- Kim, M. S., C. Y. Yoon, P. G. Jang, Y. J. Park, C. S. Shin, H. S. Park, J. W. Ryu, Y. K. Pak, J. Y. Park, K. U. Lee, S. Y. Kim, H. K. Lee, Y. B. Kim, and K. S. Park. 2004. The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol. Endocrinol. 18: 2291-2301. https://doi.org/10.1210/me.2003-0459
- Chung, H., S. Seo, M. Moon, and S. Park. 2008. Phosphatidylinositol-3-kinase/Akt/glycogen synthase kinase-3 beta and ERK1/2 pathways mediate protective effects of acylated and unacylated ghrelin against oxygen-glucose deprivation-induced apoptosis in primary rat cortical neuronal cells. J. Endocrinol. 198: 511-521. https://doi.org/10.1677/JOE-08-0160
- Bonfili, L., M. Cuccioloni, V. Cecarini, M. Mozzicafreddo, F. A. Palermo, P. Cocci, M. Angeletti, and A. M. Eleuteri. 2013. Ghrelin induces apoptosis in colon adenocarcinoma cells via proteasome inhibition and autophagy induction. Apoptosis 18: 1188-1200. https://doi.org/10.1007/s10495-013-0856-0
- Conconi, M. T., B. Nico, D. Guidolin, S. Baiguera, R. Spinazzi, P. Rebuffat, L. K. Malendowicz, A. Vacca, G. Carraro, P. P. Parnigotto, G. G. Nussdorfer, and D. Ribatti. 2004. Ghrelin inhibits FGF-2-mediated angiogenesis in vitro and in vivo. Peptides 25: 2179-2185. https://doi.org/10.1016/j.peptides.2004.08.011
- Lam, E. W., J. J. Brosens, A. R. Gomes, and C. Y. Koo. 2013. Forkhead box proteins: tuning forks for transcriptional harmony. Nat. Rev. Cancer 13: 482-495. https://doi.org/10.1038/nrc3539
- Dong, S., S. Kang, T. L. Gu, S. Kardar, H. Fu, S. Lonial, H. J. Khoury, F. Khuri, and J. Chen. 2007. 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells. Blood 110: 360-369. https://doi.org/10.1182/blood-2006-12-065615